2024 연구자 정보 (20 / 1073)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kim, Tae Yong (Kim, TY) |
Seoul Natl Univ Hosp, Oncol Dept, Seoul, South Korea |
|
|
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | msasako2010@yahoo.co.jp | ||
|
Kim, Young Bin (Kim, YB) |
Korea Adv Inst Sci & Technol KAIST, Dept Mat Sci & Engn, 291 Daehak Ro, Daejeon 34141, South Korea |
|
|
[JCR상위 1.0%] Light-Material Interactions Using Laser and Flash Sources for Energy Conversion and Storage Applications | SCIE | 1.0 |
MATERIALS SCIENCE, MULTIDISCIPLINARY NANOSCIENCE & NANOTECHNOLOGY PHYSICS, APPLIED |
kipark@knu.ac.kr keonlee@kaist.ac.kr jhryu@ynu.ac.kr |
||
|
Kim, Young-Woo (Kim, YW) |
Natl Canc Ctr, Ctr Gastr Canc, Surg Dept, Goyang, South Korea Natl Canc Ctr, Ctr Gastr Canc Res Inst & Hosp, Grad Sch Canc Sci & Policy, Goyang, South Korea |
ABD-7016-2020 Kim, Yuriy |
|
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial [JCR상위 1.7%] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY |
SCIE | 1.0 |
GASTROENTEROLOGY & HEPATOLOGY ONCOLOGY |
msasako2010@yahoo.co.jp ykkang@amc.seoul.kr |
||
|
Lee, Han Eol (Lee, HE) |
Jeonbuk Natl Univ, Div Adv Mat Engn, Jeonju 54896, Jeonbuk, South Korea |
AAS-6899-2020 Lee, Han |
|
[JCR상위 1.0%] Light-Material Interactions Using Laser and Flash Sources for Energy Conversion and Storage Applications | SCIE | 1.0 |
MATERIALS SCIENCE, MULTIDISCIPLINARY NANOSCIENCE & NANOTECHNOLOGY PHYSICS, APPLIED |
kipark@knu.ac.kr keonlee@kaist.ac.kr jhryu@ynu.ac.kr |
||
|
Lim, Tien-Huey (Lim, TH) |
Middlemore Hosp, Dept Gastroenterol & Hepatol, Auckland, New Zealand |
|
|
[JCR상위 1.0%] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hkucc.hku.hk | ||
|
Lim, Young-Suk (Lim, YS) |
제1저자 |
Univ Ulsan, Liver Ctr, Asan Med Ctr, Dept Gastroenterol,Coll Med, Seoul, South Korea Univ Ulsan, Coll Med, Coll Med, Seoul, South Korea Asan Med Ctr, Seoul, South Korea |
AFQ-5165-2022 Lim, Young-Suk |
0000-0002-1544-577X Lim, Young-Suk |
[JCR상위 1.0%] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study [JCR상위 1.7%] Phase Ib/IIa randomized study of heterologous ChAdOx1HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB [JCR상위 1.7%] Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis |
SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY |
mfyuen@hkucc.hku.hk tom.evans@barinthusbio.com limys@amc.seoul.kr |
|
|
Mao, Shenghua (Mao, SH) |
Vir Biotechnol, San Francisco, CA USA |
|
|
[JCR상위 1.0%] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hkucc.hku.hk | ||
|
Nakada, Takashi (Nakada, T) |
China Med Univ, China Med Univ Hosp, Div Hematol & Oncol, Taichung, Taiwan |
|
|
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | msasako2010@yahoo.co.jp | ||
|
Nguyen, Van-Toan (Nguyen, V) |
제1저자 |
Hanbat Natl Univ, Dept Civil & Environm Engn, Daejeon 34158, South Korea Korea Atom Energy Res Inst, Nucl Chem Res Div, Daejeon 34057, South Korea |
|
|
[JCR상위 1.0%] Biomass-derived materials for energy storage and electrocatalysis: recent advances and future perspectives | SCIE | 1.0 |
ENVIRONMENTAL SCIENCES SOIL SCIENCE |
catalica@uos.ac.kr namhs219@knu.ac.kr dylee82@hanbat.ac.kr |
|
|
Nishida, Yasunori (Nishida, Y) |
Keiyukai Sapporo Hosp, Dept Gastrointestinal Surg & Med Oncol, Sapporo, Japan |
|
|
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | msasako2010@yahoo.co.jp | ||
|
Omori, Takeshi (Omori, T) |
Osaka Int Canc Inst, Dept Gastroenterol Surg, Osaka, Japan |
|
|
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | msasako2010@yahoo.co.jp | ||
|
Park, Jung Hwan (Park, JH) |
제1저자 |
Kumoh Natl Inst Technol, Dept Mech Engn, Dept Aeronaut Mech & Elect Convergence Engn, 61 Daehak Ro, Gumi 39177, Gyeongbuk, South Korea Hanyang Univ, Coll Med, Coll Med, Div Endocrinol & Metab, Seoul, South Korea |
AAA-1951-2022 Park, Jung Hwan |
|
[JCR상위 1.0%] Light-Material Interactions Using Laser and Flash Sources for Energy Conversion and Storage Applications [JCR상위 6.5%] Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association |
SCIE | 1.0 |
MATERIALS SCIENCE, MULTIDISCIPLINARY NANOSCIENCE & NANOTECHNOLOGY PHYSICS, APPLIED ENDOCRINOLOGY & METABOLISM |
kipark@knu.ac.kr keonlee@kaist.ac.kr jhryu@ynu.ac.kr bwanlee@yuhs.ac |
|
|
Sakuramoto, Shinichi (Sakuramoto, S) |
Saitama Med Univ, Int Med Ctr, Dept Gastrointestinal Surg, Saitama, Japan |
|
|
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | msasako2010@yahoo.co.jp | ||
|
Sasako, Mitsuru (Sasako, M) |
교신저자 | Yodogawa Christians Hosp, Dept Surg, Osaka 5330024, Japan |
|
|
[JCR상위 1.0%] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | msasako2010@yahoo.co.jp | |
|
Tangkijvanich, Pisit (Tangkijvanich, P) |
Chulalongkorn Univ, Fac Med, Ctr Excellence Hepatitis & Liver Canc, Bangkok, Thailand |
|
|
[JCR상위 1.0%] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study | SCIE | 1.0 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hkucc.hku.hk |
페이지 이동: